Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP697580.RA_o8vah7Wd5qH-TMFl5ngwc3YWVNrAKG-phhGRBi_cZQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP697580.RA_o8vah7Wd5qH-TMFl5ngwc3YWVNrAKG-phhGRBi_cZQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP697580.RA_o8vah7Wd5qH-TMFl5ngwc3YWVNrAKG-phhGRBi_cZQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP697580.RA_o8vah7Wd5qH-TMFl5ngwc3YWVNrAKG-phhGRBi_cZQ130_provenance.
- NP697580.RA_o8vah7Wd5qH-TMFl5ngwc3YWVNrAKG-phhGRBi_cZQ130_assertion description "[Oncolytic measles virus (MV) encoding the human thyroidal sodium iodide symporter (MV-NIS) has proved to be safe after intraperitoneal or intravenous administration in patients with ovarian cancer or multiple myeloma, respectively, but it has not yet been administered through intratumoral injection in humans.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP697580.RA_o8vah7Wd5qH-TMFl5ngwc3YWVNrAKG-phhGRBi_cZQ130_provenance.
- NP697580.RA_o8vah7Wd5qH-TMFl5ngwc3YWVNrAKG-phhGRBi_cZQ130_assertion evidence source_evidence_literature NP697580.RA_o8vah7Wd5qH-TMFl5ngwc3YWVNrAKG-phhGRBi_cZQ130_provenance.
- NP697580.RA_o8vah7Wd5qH-TMFl5ngwc3YWVNrAKG-phhGRBi_cZQ130_assertion SIO_000772 22235810 NP697580.RA_o8vah7Wd5qH-TMFl5ngwc3YWVNrAKG-phhGRBi_cZQ130_provenance.
- NP697580.RA_o8vah7Wd5qH-TMFl5ngwc3YWVNrAKG-phhGRBi_cZQ130_assertion wasDerivedFrom befree-20150227 NP697580.RA_o8vah7Wd5qH-TMFl5ngwc3YWVNrAKG-phhGRBi_cZQ130_provenance.
- NP697580.RA_o8vah7Wd5qH-TMFl5ngwc3YWVNrAKG-phhGRBi_cZQ130_assertion wasGeneratedBy ECO_0000203 NP697580.RA_o8vah7Wd5qH-TMFl5ngwc3YWVNrAKG-phhGRBi_cZQ130_provenance.
- befree-20150227 importedOn "2015-02-27" NP697580.RA_o8vah7Wd5qH-TMFl5ngwc3YWVNrAKG-phhGRBi_cZQ130_provenance.